anti-inflammatory (CytoMed/UCB Pharma)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-inflammatory (CytoMed/UCB Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytomed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCytomedUcb Pharma Sa
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A